Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases

Brain metastases are a common cause of death in stage IV metastatic melanoma. Dabrafenib is a BRAF (gene encoding serine/threonine-protein kinase B-Raf) inhibitor that has been developed to selectively target the valine 600 to glutamic acid substitution (BRAF(V600E)), which is commonly found in meta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mittapalli, Rajendar K., Vaidhyanathan, Shruthi, Dudek, Arkadiusz Z., Elmquist, William F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2013
Gaiak:
Metabolism, Transport, and Pharmacogenomics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583506/
https://ncbi.nlm.nih.gov/pubmed/23249624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.112.201475
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak